![Page 1: Mutation VAF Mutation CCF · 2017. 4. 25. · Tumor (all mutations) Density (a.u.) VAF T umor C o v e r age 1 0.8 0.6 0.4 0.2 0 5 10 20 50 100 200 500 1000 Mutation VAF on copy number](https://reader035.vdocument.in/reader035/viewer/2022071604/614092642e263e64232a2661/html5/thumbnails/1.jpg)
Tumor (all mutations)
Den
sity
(a.u
.)
VAF
Tum
or C
over
age
1 0.8 0.6 0.4 0.2 05
102050
100200500
1000
Mutation VAF on copy number 3
Mutation CCF on copy number 3
Mutation CCF on copy number 2
Den
sity
(a.u
.)
VAF
Tum
or C
over
age
1 0.8 0.6 0.4 0.2 05
102050
100200500
1000
Den
sity
(a.u
.)Tu
mor
Cov
erag
e
5102050
100200500
1000
Den
sity
(a.u
.)Tu
mor
Cov
erag
e
5102050
100200500
1000
Den
sity
(a.u
.)Tu
mor
Cov
erag
e
5102050
100200500
1000
Mutation VAF on copy number 2
VAF1 0.8 0.6 0.4 0.2 0
Cancer Cell Fraction1 0.8 0.6 0.4 0.2 0
Cancer Cell Fraction1 0.8 0.6 0.4 0.2 0
Mutation CCF (all muations)
Den
sity
(a.u
.)
Cancer Cell Fraction
Clonal mutationSubclonal mutation
Tum
or C
over
age
1 0.8 0.6 0.4 0.2 05
102050
100200500
1000
Figure 1
![Page 2: Mutation VAF Mutation CCF · 2017. 4. 25. · Tumor (all mutations) Density (a.u.) VAF T umor C o v e r age 1 0.8 0.6 0.4 0.2 0 5 10 20 50 100 200 500 1000 Mutation VAF on copy number](https://reader035.vdocument.in/reader035/viewer/2022071604/614092642e263e64232a2661/html5/thumbnails/2.jpg)
1/4 2/5 4/10 620/640VAF 0.13
0/20.0
0/10.0
0/10.0 0.2 0.2 0.24 0.24 0.48
VAFcellular frequency
cellular frequency
A) Mutations under positive selection
B) Mutations under neutral evolution
8/14 16/28
4/4 5/5 10/10 640/6402/21/10.5 0.5 0.5 0.5 0.5 0.5 0.5
0/10.0 0.5
14/14 28/28
1/4 2/8 160/640VAF 0.13 0.13
0/20.0
0/10.0
0/10.0 0.13 0.13
VAFcellular frequency
cellular frequency 4/16
0/4 0/8 40/640VAF 0.0 0.0
0/20.0
0/10.0
0/10.0 0.03 0.03
cellular frequency 1/16
4/4 8/8 640/6402/21/10.5 0.5 0.5 0.5 0.5
0/10.0 0.5
16/16
.....
Figure 2
![Page 3: Mutation VAF Mutation CCF · 2017. 4. 25. · Tumor (all mutations) Density (a.u.) VAF T umor C o v e r age 1 0.8 0.6 0.4 0.2 0 5 10 20 50 100 200 500 1000 Mutation VAF on copy number](https://reader035.vdocument.in/reader035/viewer/2022071604/614092642e263e64232a2661/html5/thumbnails/3.jpg)
evolutionary time
Therapy induced mutagenesis
Therapy as a selective pressure
Pre-existing resistant clone
Shift in clonal composition
Maintenance of clonal composition
A)
B)
C)
D)
therapy relapse
Figure 3